Recombinant Factor VII for Intractable Postpartum Haemorrhage

Aljazeera Hospital

Status: Completed

Conditions: Post Partum Hemorrhage

Treatments: Drug: recombinant factor VIIa

Study type: Observational

Funder types: Other

Identifiers

NCT05298826

Recombinant factor VII

Details and patient eligibility

About

Postpartum haemorrhage remains at the top of the causes of maternal deaths in both developed and developing countries .

Full description

Major postpartum haemorrhage is a dangerous complication that accounts for the highest maternal morbidity rate

Enrollment: 41 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women with severe resistant postpartum hemorage

Exclusion criteria

• women without postpartum hemorage

Trial design

41 participants in 2 patient groups

Junior staff has started the management and called for the senior staff.

Treatment:

Drug: recombinant factor VIIa

senior staff. managed the case from the start

Treatment:

Drug: recombinant factor VIIa